Status:
UNKNOWN
Comparison of Two Kinds of Biliary Intestinal Reconstruction in Cholangiectasia
Lead Sponsor:
Southwest Hospital, China
Conditions:
Postcholecystectomy Syndrome
Eligibility:
All Genders
5-70 years
Phase:
NA
Brief Summary
To observe and compare the short-term and long-term effects of different biliary and intestinal reconstruction methods for the treatment of congenital cystic dilatation of bile duct .
Detailed Description
The purpose of the study： length of operation time, postoperative intestinal function recovery time as the main index, application prospective clinical study to observe the differences were followed b...
Eligibility Criteria
Inclusion
- gender, age 5-70 years old (the disease can occur at any age, but in 80% cases of childhood onset, such as children's height and weight of endoscopic treatment for the standard, by parents as guardians into the group);
- preoperative congenital cystic dilatation of the bile duct (I, II, IV) clear diagnosis; preoperative assessment of liver function
- : Child-Pugh = B;
- bile duct without canceration;
- recurrent cholangitis, biliary calculi in the biliary tract infection was controlled in acute pancreatitis; control of inflammation;
- the treatment of choledochal cyst, without any surgical treatment;
- the general condition of the patient, heart and lung function can tolerate surgery, no absolute contraindication abdominal laparoscopic operation;
- voluntarily participated in the study, informed consent.
Exclusion
- congenital cystic dilatation of the bile duct of III type, V type (III type feasible endoscope end of bile duct duodenal sphincterotomy, V type partial resection of the liver);
- patients who cannot tolerate pneumoperitoneum or serious abdominal adhesions, unable to carry out laparoscopic surgery;
- bad general condition or heart pulmonary dysfunction cannot tolerate surgery;
- severe cholestatic cirrhosis, severe portal hypertension;
- high risk patients with general anesthesia.
Key Trial Info
Start Date :
June 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2020
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03401424
Start Date
June 1 2017
End Date
June 1 2020
Last Update
January 17 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Southwest Hospital
Chongqing, Chongqing Municipality, China, 400038